Monday, May 29, 2023
  • Home
  • Featured
  • Parenting
  • Pregnancy
  • Birth
  • Lifestyle
  • Shop
Baby Care News
  • Home
  • Featured
  • Parenting
  • Pregnancy
  • Birth
  • Lifestyle
  • Shop
No Result
View All Result
  • Home
  • Featured
  • Parenting
  • Pregnancy
  • Birth
  • Lifestyle
  • Shop
No Result
View All Result
Baby Care News
No Result
View All Result
Home Pregnancy

Antidepressant Use During Pregnancy Shows No Increased Risk of Neurodevelopmental Disorders in Children

by Baby Care News
October 20, 2022
in Pregnancy
Reading Time: 2 mins read
A A
0
Antidepressant Use During Pregnancy Shows No Increased Risk of Neurodevelopmental Disorders in Children
Share on FacebookShare on Twitter


Using health care utilization data and controlling for confounding by indication, environment, and genetics, findings from a recently published study of nearly 150,000 antidepressant-exposed pregnancies showed that use of these medications during pregnancy itself does not increase the risk of neurodevelopmental disorders (NDDs) in children. However, this may indicate the need to screen and intervene early, as there are strong associations.1

The defined pregnancy groups were nested in both the Medicaid Analytic eXtract(MAX), which contains health care utilization data for Medicaid beneficiaries nationwide, 2000-2014, and the MarketScan Commercial Claims Database which contains private health insurance claims data, 2003-2015. The total number of pregnancies exposed to antidepressants at late pregnancy was 93,069, 52,633 and 1,833,927 respectively.

Led by Elizabeth A. Suarez, PhD, MPH, pharmacoepidemiologist, Rutgers Institute for Health, Health Care Policy and Aging Research, the study followed children from birth until outcome diagnosis, disenrollment, death, or end of study (maximum, 14 years). Neurodevelopmental outcomes included diagnosis of autism spectrum disorder (ASD), attention defect disorder (ADHD), certain learning disorders, developmental speech/language disorders, developmental coordination disorder or intellectual disability and any NDD (presence any of the 7 specific disorders).

Children of antidepressant-exposed parents had a higher incidence of NDDs. At 12 years old, 46.8% (95%CI, 45.6-48.1), and 24.9% (95%CI, 23.0-26.9) of the MAX cohort had experienced any type of NDD. This was compared to 31.4% (95%CI, 31.1-31.6) or 15.1% (95%CI, 14.7-15.4) for unexposed children in the same cohorts. ADHD was the most common individual outcome in NDD. There were 33.3% (95%CI), 32.2-34.5 and 20.3% (95%CI), 20.0-20.9) incidence rates for those who took antidepressants in MAX or MarketScan. These rates were lower than the 17.6% (95%CI), 15.8-19.5) and 9.6% (95%CI), 9.3-10.0 for unexposed individuals.

The incidence of ASD was similarly higher in antidepressant-exposed children and publicly insured children. At 12 years, 4.1% (95% CI, 3.5-4.7) and 2.1% (95% CI, 2.0-2.1) of antidepressant-exposed children developed ASD vs 2.9% (95% CI, 2.4-3.6) and 1.6% (95% CI, 1.4-1.7) of those unexposed to treatment in the same cohorts, respectively. Crude HRs of all NDD outcomes indicated an increase in risk. HRs ranged between 1.32 and 2.02 for ADHD in children exposed to antidepressants during pregnancy compared to those who were not. After adjusting to measure covariates and proxy for unmeasured variables, HRs for all NDDS were significantly reduced, ranging between 1.01 for certain learning disorders and 1.20 for ADHD.

The sibling design was not subject to sensitivity analysis. These analyses did not show that there were any carryover effects from the first pregnancy’s exposure to the outcome of the second. The study included several antidepressants, but no one therapy was found to significantly increase the risk of NDD. The adjusted HRs for escitalopram across all outcomes was comparable to those for other drugs and classes. Results were also similar for all ages regardless of whether they were exposed in the late or early stages of pregnancy when NDD risk was calculated based on antidepressant timing.

REFERENCE
1.Suarez EA, Bateman BT, Hernandez-Diaz S, et al. Association of antidepressant use in pregnancy with the risk of neurodevelopmental disorder in children. JAMA Intern Med. Published online October 3, 2022. doi:10.1001/jamainternmed.2022.4268



Source link

Tags: antidepressantChildrendisordersIncreasedneurodevelopmentalpregnancyRiskShows
Previous Post

Quebec MNAs announce birth of son

Next Post

‘You Are Right to Cry’

Related Posts

How Can pregnant women keep cool and comfortable in peak summer?
Pregnancy

How Can pregnant women keep cool and comfortable in peak summer?

May 29, 2023
Michael Jordan, who is expected to be worth $2 billion, survived a “near miscarriage” during Deloris’ pregnancy: “There might be something wrong”
Pregnancy

Michael Jordan, who is expected to be worth $2 billion, survived a “near miscarriage” during Deloris’ pregnancy: “There might be something wrong”

May 28, 2023
Claire Holt Recalls Miscarriage Fears Amid 3rd Pregnancy
Pregnancy

Claire Holt Recalls Miscarriage Fears Amid 3rd Pregnancy

May 27, 2023
A lawsuit claims that a restaurant manager was fired for asking for COVID masks and security while pregnant.
Pregnancy

A lawsuit claims that a restaurant manager was fired for asking for COVID masks and security while pregnant.

May 26, 2023
I’m a mom – pregnancy and breastfeeding gave me the boob job I’ve always wanted, I hope I get to keep them
Pregnancy

I’m a mom – pregnancy and breastfeeding gave me the boob job I’ve always wanted, I hope I get to keep them

May 25, 2023
Clinical Trials Day, 2023: Strategic Approaches to Pregnancy and Nursing: Time for a paradigm shift
Pregnancy

Clinical Trials Day, 2023: Strategic Approaches to Pregnancy and Nursing: Time for a paradigm shift

May 24, 2023
Next Post
‘You Are Right to Cry’

'You Are Right to Cry'

IVF Babies Born to Black Mothers Face Higher Infant Mortality Rates

IVF Babies Born to Black Mothers Face Higher Infant Mortality Rates

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us
BABY CARE NEWS

Copyright © 2023 - Baby Care News.
Baby Care News is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Featured
  • Parenting
  • Pregnancy
  • Birth
  • Lifestyle
  • Shop

Copyright © 2023 - Baby Care News.
Baby Care News is not responsible for the content of external sites.